About Tokai University Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Tokai University Hospital
During the past decade, Tokai University Hospital conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 18 clinical trials were completed, i.e. on
average, 41.9% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 13 clinical trials were completed. i.e. 92.9%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
2013-10-01
2016-04-01
Completed
711
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections
2014-10-06
2015-08-21
Completed
908
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
2014-11-27
2018-08-14
Completed
5,390
Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis
2015-09-01
2017-04-04
Completed
572
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Tokai University Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Takeda" with 4 trials
sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "Celgene" with 3 trials sponsored and "Eli Lilly and Company"
with 3 trials sponsored. Other sponsors include 35 different institutions and
companies that sponsored additional 36 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tokai University Hospital"
#1 collaborator was "Boehringer Ingelheim" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at Tokai University Hospital
According to Clinical.Site data, the most researched conditions in "Tokai University Hospital" are
"Multiple Myeloma" (5 trials), "Ovarian Cancer" (4 trials), "Psoriasis" (4 trials), "Coronary Artery Disease" (3 trials) and "Fallopian Tube Cancer" (3 trials). Many other conditions were trialed in "Tokai University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Tokai University Hospital
Most popular intervention types in "Tokai University Hospital" are "Drug" (42 trials), "Device" (8 trials), "Biological" (4 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "BMS-986165" (3 trials), "Dexamethasone" (3 trials), "parsaclisib" (3 trials) and "placebo" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Tokai University Hospital
The vast majority of trials in "Tokai University Hospital" are
52 trials for "All" genders and 6 trials for "Female" genders.
Clinical Trials Status at Tokai University Hospital
Currently, there are NaN active trials in "Tokai University Hospital".
undefined are not yet recruiting,
10 are recruiting,
12 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 30 completed trials in Tokai University Hospital,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Tokai University Hospital, 5 "Phase 1"
clinical trials were conducted, 16 "Phase 2" clinical
trials and 29 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 6 trials that are defined as “Not Applicable".